Clinical Trial Update: Study of AVZO-021 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update shows AVZO-021 is in Phase 1/2 for advanced solid tumors including HR+/HER2- breast cancer and several gynecologic cancers; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Endometrial Cancer
• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• AVZO-021

Snippet

Sponsor: Avenzo Therapeutics, Inc. | Conditions: Advanced Solid Tumor, HR+/HER2- Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING